Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
871 participants
OBSERVATIONAL
2009-04-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Web and Shared Decision Making for Reserve/National Guard Women's PTSD Care
NCT01710306
Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas
NCT03429166
Addressing the Health Concerns of VA Women With Sexual Trauma
NCT02957747
Impact of Pre-Military Life Experiences/Exposures on Active-Duty Service Members' Psychological Health
NCT06070025
Stress, Emotion Regulation, and Alcohol in Women Veterans
NCT04393623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: The objectives are: 1) To identify and describe organizational, situational, and individual risk factors for physical and sexual assault (i.e., victimization) in women who have served or are currently serving in the Regular Military in Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) by deployment status (those who are deployed to combat related regions once, those deployed more than once, those serving in non-combat related areas outside of the continental United States (US), or those serving within the continental US. 2) To determine associations between PTSD, TBI, and physical and sexual assault during OEF/OIF with current physical and mental health status and health risk behaviors by deployment status. 3) To identify current internal and external barriers to DoD, DVA, and civilian health services in relationship to women's deployment and victimization status and the association between PTSD and TBI; 4) To identify and describe differences between Regular Military and R/NG populations for each of these objectives.
Methods: We propose a cross sectional study design with two sequential phases. Phase 1 would include focus groups to refine the current study interview specific to Regular Military populations. Phase 2 would involve the identification and successful interviewing of 669 Regular Military service women, using random sampling with stratification by deployment status, state of service accession, and service branch. Building on our current study, women will be selected from five states: Iowa, Illinois, Kansas, Missouri, and Nebraska. Potential study participants will be mailed an information summary and asked to take part in a study assessing the deployment health of military women. 1058 women will be contacted to obtain the target of 669 completed interviews. Consenting participants (167 per deployment group) will complete a telephone interview that assesses socio-demographic variables, trauma exposures, health history, current health status, military environmental factors (organizational and situational factors), military and DVA health care and barriers to this care, and self reported service use. Descriptive analysis and multiple logistic regression analysis will be used.
Implications: It is unclear if the needs of military women are met by current combat-associated PTSD treatments originally based on male populations. It is anticipated that our findings will improve understanding of the health risks and outcomes of deployed Regular Military service women in contrast to women serving in the R/NG (with PTSD and TBI as key outcome variables). Our results consequently will have implications for DoD and DVA evidence based interventions for both primary prevention and care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
D0
Not deployed
No interventions assigned to this group
D1
Deployed to combat-related regions once
No interventions assigned to this group
D2
Deployed to combat related regions more than once
No interventions assigned to this group
D3
Deployed outside of the continental US but not to combat related regions
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men or women who have or are currently active duty regular military (RM) of OIF/OEF service eras (10/7/01- present)
* Interview phase:
* Women, who have or are currently serving active duty RM during OIF/OEF service eras
Exclusion Criteria
* Disabilities that render incapable of hearing
* Comprehending
* Communicating in a group or inhibit travel to focus group
* Interview phase:
* Disabilities that render incapable of hearing
* Comprehending
* Communicating independently with interviewers by telephone
* Not having telephone and unable to access a nearby VA or other possible resource to contact toll free number.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
US Department of Veterans Affairs
FED
Iowa City Veterans Affairs Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne G SAdler
CADRE Core Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne G Sadler, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
US Department of Veterans Affairs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anne G. Sadler, Ph.D.; VAMC
Iowa City, Iowa, United States
Iowa City VAMC
Iowa City, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRANT00341283 (USAMRMC)
Identifier Type: -
Identifier Source: secondary_id
DHI08-136 (DVA)
Identifier Type: -
Identifier Source: secondary_id
PT075819
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.